Home > Managing Your Treatment > Management Tips

Management Tips

When you are managing treatment for PI, it’s important to keep track of several different factors. There are five things every person living with primary immunodeficiency should know to help manage immunoglobulin (Ig) treatment, whether it’s given into a vein (intravenously or IV) or under the skin (subcutaneously or SubQ).


 

Five Things You Should Know About Your Ig Treatment

  1. Brand: Every IV and SubQ brand is made, processed, and stabilized in a different way. These differences in Ig formulations might make one brand more suitable for you than another.1 Being aware of the brand your healthcare provider has prescribed allows you to make sure it’s used for each infusion. Be aware that side effects may occur more frequently in patients receiving Ig for the first time, upon switching brands or if there has been a long interval since the previous infusion. In such cases, your physician may start your infusion at a lower infusion rate and gradually increase the rate as tolerated.
  2. Dosage: Your physician may need to adjust your dose to achieve the desired clinical response. Your dosage may also need to be adjusted, as it is based on weight and PI condition, which may vary over time.
  3. Rate of infusion: You may find that you respond differently to different rates of infusion. Slowing down the rate of infusion can sometimes reduce side effects.2
  4. How to keep an infusion log: Tracking your response to brand, dosage, and frequency of infusion can be beneficial to both you and your treatment team. An infusion log helps you track and maintain a consistent infusion schedule.
  5. Where your Ig treatment comes from: It also helps to know how your Ig treatment (IV or SubQ) brand is processed. To learn more about the Shire manufacturing process and plasma collection, view About Plasma Treatment.

References: 1. Younger MEM, ed. IDF Guide for Nurses on Immune Globulin Therapy for Primary Immunodeficiency Diseases. 3rd ed. Towson, MD: Immune Deficiency Foundation; 2012. 2. Blaese RM, Bonilla FA, Stiehm ER, Younger ME, eds. Patient & Family Handbook for Primary Immunodeficiency Diseases. 5th ed. Towson, MD: Immune Deficiency Foundation; 2013

    

  • Sign up to get access to experienced Patient and Nurse Advocates, insurance and financial support, useful tools, and more.
    Enroll Now
  • 
  • Ask an Advocate Questions about PI or PI treatments? Our trained Patient and Nurse Advocates can help, and asking your question is easy with our Ask An Advocate feature.
    Start Getting Answers

You are now leaving GAMMAGARD.com

Shire is not responsible for the privacy policy, the content or the accuracy of any web site accessed through a link on the GAMMAGARD.com site. A link to other web sites does not constitute an endorsement of Shire of the linked site, its products or services.

The browser window or tab for GAMMAGARD.com will remain open underneath the new browser window or tab. To return to GAMMAGARD.com at any time, close this tab or window.

Return to
GAMMAGARD.com
Continue

Terms and Conditions

Patient instructions

  1. By using this coupon, you are certifying that:
  2. 1) You meet the eligibility criteria and have read and agree to the terms and conditions of this manufacturer coupon program;
  3. 2) You will not, at any time, submit any costs for the product dispensed pursuant to this coupon to any government healthcare program for reimbursement;
  4. 3) You are permitting your personal information, including name, address, phone number, email address, and information related to health insurance and treatment, to be shared with Shire and companies working with Shire for the purpose of administering this program; and
  5. 4) You will notify your health insurance provider or other third-party payer of the use of this coupon if required to do so.
  6. If your insurance situation changes it is your responsibility to notify Shire's MyIgCoPayCard program.
  7. For questions about this program, patients and caregivers can call MyIgSource at (855) 250-5111.

Pharmacy instructions

  1. By submitting a claim for reimbursement pursuant to this manufacturer coupon program, the Pharmacy represents and warrants that:
  2. 1) It has dispensed GAMMAGARD LIQUID treatment to an eligible patient and in accordance with the terms and conditions of this program and the accompanying prescription;
  3. 2) Its participation in this program is consistent with all applicable laws and any obligations, including its contract with the applicable payer;
  4. 3) If the patient's insurance situation changes, it will notify Shire immediately by contacting the MyIgCoPayCard program;
  5. 4) It will report coupon assistance received to payers if so required; and
  6. 5) The entire benefit amount received will go to eligible expenses and it will not retain any portion of the benefit as payment to it for administration or ineligible expenses.
  7. For questions regarding processing, claim transmission, patient eligibility, or other issues, pharmacists can call the MyIgCoPayCard program directly at (855) 217-1615.